- Perpetually Adaptive Enterprise Press tab for submenu items
Where adaptability meets advantage
At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
-
Industries
-
Services
-
Products and Platforms
-
Research & Innovation
-
Alliances
Perpetually Adaptive Enterprise
Industries
expand here
Services
expand here
Products and Platforms
expand here
Research & Innovation
expand here
- About Us Press tab for submenu items
We deliver excellence and create value for customers and communities.
Our expert, committed team put our shared values into action – every day. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
-
Brand
-
Leadership
-
Community
-
Sustainability
-
Inclusion
-
Values
- Customer Stories Press tab for submenu items
Discover why customers choose TCS
We are a digital transformation and technology partner of choice for industry-leading organizations worldwide.
-
Events
Upcoming events
29 Sep 2025 TCS BaNCS and Quartz at SIBOS 2025, Frankfurt22 Sep 2025 TCS Life Sciences Forum 2025 LondonView all16 Sep 2025 Shaping Tomorrow through AI -
Analyst Recognition
-
Global Studies
- Build a future with us Press tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Build a future with us
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
Investor Relations
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
- Worldwide Press tab for submenu items
Global knowledge. Local support
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
-
Global
-
Localized sites
Top Results
Showing
10
01 - 07
Next-gen clinical trials via digital platform
Matthew Moyer, Director - Operations and supply tech, Merck, and Narayanan R., Chief Architect - TCS ADD™, discuss and demonstrate approaches and real-life examples to enable patient-centric trials through a unified, integrated platform.
14 MINS WATCH
You have these already downloaded
We have sent you a copy of the report to your email again.
Products and Platforms
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
Meet our leadership team to learn about PV transformation expertise and experience our TCS ADD™ Safety -- An AI Platform for Pharmacovigilance. Join us now.
Events
29 Aug 2023
TCS is a Diamond sponsor at World Drug Safety Congress Americas 2022. Meet the team to know more about TCS ADD™ Safety – An AI Platform for Pharmacovigilance.
Events
04 Oct 2022
Highlights
- Merck partnered with TCS to realize its vision of a digitally enabled trials platform (DETP), leveraging TCS ADD’s decentralized trials solution.
- Merck and TCS jointly tested a host of features such as electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer, and bring-your-own-device (BYOD).
- The digitally enabled trials platform (DETP) aims to resolve challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy, and calculating RoI.
Enabling patient-centric trials
Clinical trials have been primarily driven by a site-centric approach (such as face-to-face interactions at the site).
The COVID-19 pandemic severely impacted the functioning of traditional clinical trials and opened a world of possibilities to move to the next generation of clinical trials. Augmented by digital technologies, clinical trials improve participant access, engagement enabling patient-centricity.
Merck partnered with TCS to realize its vision of a digitally enabled trials platform (DETP), leveraging TCS ADD’s decentralized trials solution. The DETP was aimed at resolving challenges around protocol impact, supplier qualification and GxP procedures, managing data privacy, and calculating RoI.
The partnership facilitated a host of features being actively tested, viz-a-viz, electronic date capture from device and reporting, auto reminders, interim data storage, API, passive data transfer, and BYOD.
Related reading
1/4
Automation of Trial Design Domains Generation Using AI
Article
|
11 Aug 2025
Opens in new tab
2/4
Solutions
TCS ADD™ Medical Monitoring: Revolutionize Subject Data Analysis
Solution
|
24 Jun 2025
Opens in new tab
3/4
Artificial Intelligence – A Game Changer in Unifying Clinical Data
Article
|
20 May 2025
Opens in new tab
4/4
TCS ADD™ Webinar: Shaping the Future of AI-driven SDTM Harmonization
video
|
22 Apr 2025
Opens in new tab
Transformation starts here
Integrated ecosystems are key to better patient outcomes.
Talk to our expertsFind out more
©2025 TATA Consultancy Services Limited
©2025 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Accessibility Declaration
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?